PPARG and Alzheimer disease: Further strata, representing intermediate developmental stages between a strict delineation of type I and type II groups or additional consideration of homeostatic compensatory mechanisms implicating ion channels (MRP) or cell architecture (τ and Cm) might associate these divergent parameters more exquisitely with the AD state and the effects of PPARγ agonism.